Global Insomnia Therapeutics Drugs Market Insights and Forecast to 2028

Publisher Name :
Date: 22-Feb-2022
No. of pages: 111
Inquire Before Buying

Insomnia Therapeutics Drugs market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Insomnia Therapeutics Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Benzodiazepines

Nonbenzodiazepines

Antidepressants

Orexin Antagonists

Melatonin Antagonists

Others

Segment by Application

Prescription

Over-the-Counter (OTC)

By Company

Takeda Pharmaceutical Company Ltd.

Vanda Pharmaceuticals

Merck & Co., Inc.

Pfizer Inc.

Teva Pharmaceutical Industries Ltd.

Mylan N.V.

Sumitomo Dainippon Pharma Co., Ltd

Sanofi

Paratek Pharmaceuticals Inc.

Ebb Therapeutics

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Global Insomnia Therapeutics Drugs Market Insights and Forecast to 2028

Table of Contents
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Insomnia Therapeutics Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Benzodiazepines
1.2.3 Nonbenzodiazepines
1.2.4 Antidepressants
1.2.5 Orexin Antagonists
1.2.6 Melatonin Antagonists
1.2.7 Others
1.3 Market by Application
1.3.1 Global Insomnia Therapeutics Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Prescription
1.3.3 Over-the-Counter (OTC)
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Insomnia Therapeutics Drugs Market Perspective (2017-2028)
2.2 Insomnia Therapeutics Drugs Growth Trends by Region
2.2.1 Insomnia Therapeutics Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Insomnia Therapeutics Drugs Historic Market Size by Region (2017-2022)
2.2.3 Insomnia Therapeutics Drugs Forecasted Market Size by Region (2023-2028)
2.3 Insomnia Therapeutics Drugs Market Dynamics
2.3.1 Insomnia Therapeutics Drugs Industry Trends
2.3.2 Insomnia Therapeutics Drugs Market Drivers
2.3.3 Insomnia Therapeutics Drugs Market Challenges
2.3.4 Insomnia Therapeutics Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Insomnia Therapeutics Drugs Players by Revenue
3.1.1 Global Top Insomnia Therapeutics Drugs Players by Revenue (2017-2022)
3.1.2 Global Insomnia Therapeutics Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Insomnia Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Insomnia Therapeutics Drugs Revenue
3.4 Global Insomnia Therapeutics Drugs Market Concentration Ratio
3.4.1 Global Insomnia Therapeutics Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Insomnia Therapeutics Drugs Revenue in 2021
3.5 Insomnia Therapeutics Drugs Key Players Head office and Area Served
3.6 Key Players Insomnia Therapeutics Drugs Product Solution and Service
3.7 Date of Enter into Insomnia Therapeutics Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Insomnia Therapeutics Drugs Breakdown Data by Type
4.1 Global Insomnia Therapeutics Drugs Historic Market Size by Type (2017-2022)
4.2 Global Insomnia Therapeutics Drugs Forecasted Market Size by Type (2023-2028)
5 Insomnia Therapeutics Drugs Breakdown Data by Application
5.1 Global Insomnia Therapeutics Drugs Historic Market Size by Application (2017-2022)
5.2 Global Insomnia Therapeutics Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Insomnia Therapeutics Drugs Market Size (2017-2028)
6.2 North America Insomnia Therapeutics Drugs Market Size by Type
6.2.1 North America Insomnia Therapeutics Drugs Market Size by Type (2017-2022)
6.2.2 North America Insomnia Therapeutics Drugs Market Size by Type (2023-2028)
6.2.3 North America Insomnia Therapeutics Drugs Market Share by Type (2017-2028)
6.3 North America Insomnia Therapeutics Drugs Market Size by Application
6.3.1 North America Insomnia Therapeutics Drugs Market Size by Application (2017-2022)
6.3.2 North America Insomnia Therapeutics Drugs Market Size by Application (2023-2028)
6.3.3 North America Insomnia Therapeutics Drugs Market Share by Application (2017-2028)
6.4 North America Insomnia Therapeutics Drugs Market Size by Country
6.4.1 North America Insomnia Therapeutics Drugs Market Size by Country (2017-2022)
6.4.2 North America Insomnia Therapeutics Drugs Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Insomnia Therapeutics Drugs Market Size (2017-2028)
7.2 Europe Insomnia Therapeutics Drugs Market Size by Type
7.2.1 Europe Insomnia Therapeutics Drugs Market Size by Type (2017-2022)
7.2.2 Europe Insomnia Therapeutics Drugs Market Size by Type (2023-2028)
7.2.3 Europe Insomnia Therapeutics Drugs Market Share by Type (2017-2028)
7.3 Europe Insomnia Therapeutics Drugs Market Size by Application
7.3.1 Europe Insomnia Therapeutics Drugs Market Size by Application (2017-2022)
7.3.2 Europe Insomnia Therapeutics Drugs Market Size by Application (2023-2028)
7.3.3 Europe Insomnia Therapeutics Drugs Market Share by Application (2017-2028)
7.4 Europe Insomnia Therapeutics Drugs Market Size by Country
7.4.1 Europe Insomnia Therapeutics Drugs Market Size by Country (2017-2022)
7.4.2 Europe Insomnia Therapeutics Drugs Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Insomnia Therapeutics Drugs Market Size (2017-2028)
8.2 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Type
8.2.1 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Insomnia Therapeutics Drugs Market Share by Type (2017-2028)
8.3 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Application
8.3.1 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Insomnia Therapeutics Drugs Market Share by Application (2017-2028)
8.4 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Region
8.4.1 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Insomnia Therapeutics Drugs Market Size (2017-2028)
9.2 Latin America Insomnia Therapeutics Drugs Market Size by Type
9.2.1 Latin America Insomnia Therapeutics Drugs Market Size by Type (2017-2022)
9.2.2 Latin America Insomnia Therapeutics Drugs Market Size by Type (2023-2028)
9.2.3 Latin America Insomnia Therapeutics Drugs Market Share by Type (2017-2028)
9.3 Latin America Insomnia Therapeutics Drugs Market Size by Application
9.3.1 Latin America Insomnia Therapeutics Drugs Market Size by Application (2017-2022)
9.3.2 Latin America Insomnia Therapeutics Drugs Market Size by Application (2023-2028)
9.3.3 Latin America Insomnia Therapeutics Drugs Market Share by Application (2017-2028)
9.4 Latin America Insomnia Therapeutics Drugs Market Size by Country
9.4.1 Latin America Insomnia Therapeutics Drugs Market Size by Country (2017-2022)
9.4.2 Latin America Insomnia Therapeutics Drugs Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Insomnia Therapeutics Drugs Market Size (2017-2028)
10.2 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Type
10.2.1 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Insomnia Therapeutics Drugs Market Share by Type (2017-2028)
10.3 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Application
10.3.1 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Insomnia Therapeutics Drugs Market Share by Application (2017-2028)
10.4 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Country
10.4.1 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Takeda Pharmaceutical Company Ltd.
11.1.1 Takeda Pharmaceutical Company Ltd. Company Details
11.1.2 Takeda Pharmaceutical Company Ltd. Business Overview
11.1.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Introduction
11.1.4 Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapeutics Drugs Business (2017-2022)
11.1.5 Takeda Pharmaceutical Company Ltd. Recent Developments
11.2 Vanda Pharmaceuticals
11.2.1 Vanda Pharmaceuticals Company Details
11.2.2 Vanda Pharmaceuticals Business Overview
11.2.3 Vanda Pharmaceuticals Insomnia Therapeutics Drugs Introduction
11.2.4 Vanda Pharmaceuticals Revenue in Insomnia Therapeutics Drugs Business (2017-2022)
11.2.5 Vanda Pharmaceuticals Recent Developments
11.3 Merck & Co., Inc.
11.3.1 Merck & Co., Inc. Company Details
11.3.2 Merck & Co., Inc. Business Overview
11.3.3 Merck & Co., Inc. Insomnia Therapeutics Drugs Introduction
11.3.4 Merck & Co., Inc. Revenue in Insomnia Therapeutics Drugs Business (2017-2022)
11.3.5 Merck & Co., Inc. Recent Developments
11.4 Pfizer Inc.
11.4.1 Pfizer Inc. Company Details
11.4.2 Pfizer Inc. Business Overview
11.4.3 Pfizer Inc. Insomnia Therapeutics Drugs Introduction
11.4.4 Pfizer Inc. Revenue in Insomnia Therapeutics Drugs Business (2017-2022)
11.4.5 Pfizer Inc. Recent Developments
11.5 Teva Pharmaceutical Industries Ltd.
11.5.1 Teva Pharmaceutical Industries Ltd. Company Details
11.5.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.5.3 Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Introduction
11.5.4 Teva Pharmaceutical Industries Ltd. Revenue in Insomnia Therapeutics Drugs Business (2017-2022)
11.5.5 Teva Pharmaceutical Industries Ltd. Recent Developments
11.6 Mylan N.V.
11.6.1 Mylan N.V. Company Details
11.6.2 Mylan N.V. Business Overview
11.6.3 Mylan N.V. Insomnia Therapeutics Drugs Introduction
11.6.4 Mylan N.V. Revenue in Insomnia Therapeutics Drugs Business (2017-2022)
11.6.5 Mylan N.V. Recent Developments
11.7 Sumitomo Dainippon Pharma Co., Ltd
11.7.1 Sumitomo Dainippon Pharma Co., Ltd Company Details
11.7.2 Sumitomo Dainippon Pharma Co., Ltd Business Overview
11.7.3 Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Introduction
11.7.4 Sumitomo Dainippon Pharma Co., Ltd Revenue in Insomnia Therapeutics Drugs Business (2017-2022)
11.7.5 Sumitomo Dainippon Pharma Co., Ltd Recent Developments
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Insomnia Therapeutics Drugs Introduction
11.8.4 Sanofi Revenue in Insomnia Therapeutics Drugs Business (2017-2022)
11.8.5 Sanofi Recent Developments
11.9 Paratek Pharmaceuticals Inc.
11.9.1 Paratek Pharmaceuticals Inc. Company Details
11.9.2 Paratek Pharmaceuticals Inc. Business Overview
11.9.3 Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Introduction
11.9.4 Paratek Pharmaceuticals Inc. Revenue in Insomnia Therapeutics Drugs Business (2017-2022)
11.9.5 Paratek Pharmaceuticals Inc. Recent Developments
11.10 Ebb Therapeutics
11.10.1 Ebb Therapeutics Company Details
11.10.2 Ebb Therapeutics Business Overview
11.10.3 Ebb Therapeutics Insomnia Therapeutics Drugs Introduction
11.10.4 Ebb Therapeutics Revenue in Insomnia Therapeutics Drugs Business (2017-2022)
11.10.5 Ebb Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Insomnia Therapeutics Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Benzodiazepines
Table 3. Key Players of Nonbenzodiazepines
Table 4. Key Players of Antidepressants
Table 5. Key Players of Orexin Antagonists
Table 6. Key Players of Melatonin Antagonists
Table 7. Key Players of Others
Table 8. Global Insomnia Therapeutics Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 9. Global Insomnia Therapeutics Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global Insomnia Therapeutics Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 11. Global Insomnia Therapeutics Drugs Market Share by Region (2017-2022)
Table 12. Global Insomnia Therapeutics Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 13. Global Insomnia Therapeutics Drugs Market Share by Region (2023-2028)
Table 14. Insomnia Therapeutics Drugs Market Trends
Table 15. Insomnia Therapeutics Drugs Market Drivers
Table 16. Insomnia Therapeutics Drugs Market Challenges
Table 17. Insomnia Therapeutics Drugs Market Restraints
Table 18. Global Insomnia Therapeutics Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 19. Global Insomnia Therapeutics Drugs Revenue Share by Players (2017-2022)
Table 20. Global Top Insomnia Therapeutics Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Therapeutics Drugs as of 2021)
Table 21. Ranking of Global Top Insomnia Therapeutics Drugs Companies by Revenue (US$ Million) in 2021
Table 22. Global 5 Largest Players Market Share by Insomnia Therapeutics Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Insomnia Therapeutics Drugs Product Solution and Service
Table 25. Date of Enter into Insomnia Therapeutics Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Insomnia Therapeutics Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 28. Global Insomnia Therapeutics Drugs Revenue Market Share by Type (2017-2022)
Table 29. Global Insomnia Therapeutics Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 30. Global Insomnia Therapeutics Drugs Revenue Market Share by Type (2023-2028)
Table 31. Global Insomnia Therapeutics Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 32. Global Insomnia Therapeutics Drugs Revenue Share by Application (2017-2022)
Table 33. Global Insomnia Therapeutics Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 34. Global Insomnia Therapeutics Drugs Revenue Share by Application (2023-2028)
Table 35. North America Insomnia Therapeutics Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 36. North America Insomnia Therapeutics Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 37. North America Insomnia Therapeutics Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 38. North America Insomnia Therapeutics Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 39. North America Insomnia Therapeutics Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 40. North America Insomnia Therapeutics Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 41. Europe Insomnia Therapeutics Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 42. Europe Insomnia Therapeutics Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 43. Europe Insomnia Therapeutics Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 44. Europe Insomnia Therapeutics Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 45. Europe Insomnia Therapeutics Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 46. Europe Insomnia Therapeutics Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 47. Asia Pacific Insomnia Therapeutics Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 48. Asia Pacific Insomnia Therapeutics Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 49. Asia Pacific Insomnia Therapeutics Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 50. Asia Pacific Insomnia Therapeutics Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 51. Asia Pacific Insomnia Therapeutics Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 52. Asia Pacific Insomnia Therapeutics Drugs Market Size by Region (2023-2028) & (US$ Million)
Table 53. Latin America Insomnia Therapeutics Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 54. Latin America Insomnia Therapeutics Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 55. Latin America Insomnia Therapeutics Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 56. Latin America Insomnia Therapeutics Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 57. Latin America Insomnia Therapeutics Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 58. Latin America Insomnia Therapeutics Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Insomnia Therapeutics Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Insomnia Therapeutics Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Insomnia Therapeutics Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Insomnia Therapeutics Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 63. Middle East and Africa Insomnia Therapeutics Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 64. Middle East and Africa Insomnia Therapeutics Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 65. Takeda Pharmaceutical Company Ltd. Company Details
Table 66. Takeda Pharmaceutical Company Ltd. Business Overview
Table 67. Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Product
Table 68. Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapeutics Drugs Business (2017-2022) & (US$ Million)
Table 69. Takeda Pharmaceutical Company Ltd. Recent Developments
Table 70. Vanda Pharmaceuticals Company Details
Table 71. Vanda Pharmaceuticals Business Overview
Table 72. Vanda Pharmaceuticals Insomnia Therapeutics Drugs Product
Table 73. Vanda Pharmaceuticals Revenue in Insomnia Therapeutics Drugs Business (2017-2022) & (US$ Million)
Table 74. Vanda Pharmaceuticals Recent Developments
Table 75. Merck & Co., Inc. Company Details
Table 76. Merck & Co., Inc. Business Overview
Table 77. Merck & Co., Inc. Insomnia Therapeutics Drugs Product
Table 78. Merck & Co., Inc. Revenue in Insomnia Therapeutics Drugs Business (2017-2022) & (US$ Million)
Table 79. Merck & Co., Inc. Recent Developments
Table 80. Pfizer Inc. Company Details
Table 81. Pfizer Inc. Business Overview
Table 82. Pfizer Inc. Insomnia Therapeutics Drugs Product
Table 83. Pfizer Inc. Revenue in Insomnia Therapeutics Drugs Business (2017-2022) & (US$ Million)
Table 84. Pfizer Inc. Recent Developments
Table 85. Teva Pharmaceutical Industries Ltd. Company Details
Table 86. Teva Pharmaceutical Industries Ltd. Business Overview
Table 87. Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Product
Table 88. Teva Pharmaceutical Industries Ltd. Revenue in Insomnia Therapeutics Drugs Business (2017-2022) & (US$ Million)
Table 89. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 90. Mylan N.V. Company Details
Table 91. Mylan N.V. Business Overview
Table 92. Mylan N.V. Insomnia Therapeutics Drugs Product
Table 93. Mylan N.V. Revenue in Insomnia Therapeutics Drugs Business (2017-2022) & (US$ Million)
Table 94. Mylan N.V. Recent Developments
Table 95. Sumitomo Dainippon Pharma Co., Ltd Company Details
Table 96. Sumitomo Dainippon Pharma Co., Ltd Business Overview
Table 97. Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Product
Table 98. Sumitomo Dainippon Pharma Co., Ltd Revenue in Insomnia Therapeutics Drugs Business (2017-2022) & (US$ Million)
Table 99. Sumitomo Dainippon Pharma Co., Ltd Recent Developments
Table 100. Sanofi Company Details
Table 101. Sanofi Business Overview
Table 102. Sanofi Insomnia Therapeutics Drugs Product
Table 103. Sanofi Revenue in Insomnia Therapeutics Drugs Business (2017-2022) & (US$ Million)
Table 104. Sanofi Recent Developments
Table 105. Paratek Pharmaceuticals Inc. Company Details
Table 106. Paratek Pharmaceuticals Inc. Business Overview
Table 107. Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Product
Table 108. Paratek Pharmaceuticals Inc. Revenue in Insomnia Therapeutics Drugs Business (2017-2022) & (US$ Million)
Table 109. Paratek Pharmaceuticals Inc. Recent Developments
Table 110. Ebb Therapeutics Company Details
Table 111. Ebb Therapeutics Business Overview
Table 112. Ebb Therapeutics Insomnia Therapeutics Drugs Product
Table 113. Ebb Therapeutics Revenue in Insomnia Therapeutics Drugs Business (2017-2022) & (US$ Million)
Table 114. Ebb Therapeutics Recent Developments
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Insomnia Therapeutics Drugs Market Share by Type: 2021 VS 2028
Figure 2. Benzodiazepines Features
Figure 3. Nonbenzodiazepines Features
Figure 4. Antidepressants Features
Figure 5. Orexin Antagonists Features
Figure 6. Melatonin Antagonists Features
Figure 7. Others Features
Figure 8. Global Insomnia Therapeutics Drugs Market Share by Application: 2021 VS 2028
Figure 9. Prescription Case Studies
Figure 10. Over-the-Counter (OTC) Case Studies
Figure 11. Insomnia Therapeutics Drugs Report Years Considered
Figure 12. Global Insomnia Therapeutics Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Insomnia Therapeutics Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Insomnia Therapeutics Drugs Market Share by Region: 2021 VS 2028
Figure 15. Global Insomnia Therapeutics Drugs Market Share by Players in 2021
Figure 16. Global Top Insomnia Therapeutics Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Therapeutics Drugs as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Insomnia Therapeutics Drugs Revenue in 2021
Figure 18. North America Insomnia Therapeutics Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Insomnia Therapeutics Drugs Market Size Market Share by Type (2017-2028)
Figure 20. North America Insomnia Therapeutics Drugs Market Size Market Share by Application (2017-2028)
Figure 21. North America Insomnia Therapeutics Drugs Market Size Share by Country (2017-2028)
Figure 22. United States Insomnia Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Insomnia Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Insomnia Therapeutics Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Insomnia Therapeutics Drugs Market Size Market Share by Type (2017-2028)
Figure 26. Europe Insomnia Therapeutics Drugs Market Size Market Share by Application (2017-2028)
Figure 27. Europe Insomnia Therapeutics Drugs Market Size Share by Country (2017-2028)
Figure 28. Germany Insomnia Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Insomnia Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Insomnia Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Insomnia Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Insomnia Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Insomnia Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Insomnia Therapeutics Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Insomnia Therapeutics Drugs Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Insomnia Therapeutics Drugs Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Insomnia Therapeutics Drugs Market Size Share by Region (2017-2028)
Figure 38. China Insomnia Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Insomnia Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Insomnia Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Insomnia Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Insomnia Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Insomnia Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America Insomnia Therapeutics Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Insomnia Therapeutics Drugs Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Insomnia Therapeutics Drugs Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Insomnia Therapeutics Drugs Market Size Share by Country (2017-2028)
Figure 48. Mexico Insomnia Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Insomnia Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Insomnia Therapeutics Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Insomnia Therapeutics Drugs Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Insomnia Therapeutics Drugs Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Insomnia Therapeutics Drugs Market Size Share by Country (2017-2028)
Figure 54. Turkey Insomnia Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Insomnia Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Insomnia Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Takeda Pharmaceutical Company Ltd. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2017-2022)
Figure 58. Vanda Pharmaceuticals Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2017-2022)
Figure 59. Merck & Co., Inc. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2017-2022)
Figure 60. Pfizer Inc. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2017-2022)
Figure 61. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2017-2022)
Figure 62. Mylan N.V. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2017-2022)
Figure 63. Sumitomo Dainippon Pharma Co., Ltd Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2017-2022)
Figure 64. Sanofi Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2017-2022)
Figure 65. Paratek Pharmaceuticals Inc. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2017-2022)
Figure 66. Ebb Therapeutics Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs